TMCnet News
Research and Markets: Global Companion Diagnostics (CDx) Market 2013-2016DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/bw98wn/companion) has announced the addition of the "Global Companion Diagnostics (CDx) Market 2013-2016" report to their offering. This report reviews the size, segmentation, growth, competitive, and regulatory landscape of the companion diagnostics manufacturing market, focusing on the drug-test combinations that are considered required by the FDA. In this first edition of this CDx report, we provide estimates of the U.S. and worldwide markets for FDA approved CDx tests from 2008 to 2016 and segmentations by regulatory status (IVD, LDT), biomarker (HER2, ALK, KRAS, EGFR, ER/PR, CD20, future tests, others), therapeutic area (breast cancer, lung cancer, colon cancer, leukemia/lymphoma, other cancers, non-cancers), assay technology (FISH, IHC, sequencing, qPCR, flow cytometry, others), testing site (reference lab, hospital lab), geography (U.S., Europe, Japan, APAC, ROW), and company (Qiagen, Abbott, Dako, Roche, reference labs, others). We also identify growth drivers and moderators, as well as challenges and opportunities for the CDx market. Additionally, this report analyzes the coverage and reimbursement landscape, the impact of macroeconomic events, and the current and future regulatory environment. In this report we categorize CDx tests as either required,' recommended,' or information only' dependingon the regulatory status and testing instructions contained within the drug label. Other key points discussed here include:
Lastly, this report provides detailed analyses of the companies, biomarkers, and drugs associated with companion diagnostic testing. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Companion Diagnostics Market Overview
4. CDx Market Size
5. Companion Diagnostics Competitors
6. Key Factors Impacting the CDx Market
7. CDx Regulation
8. CDx Business Models
9. CDx Opportunities and Challenges 10. Appendix For more information visit http://www.researchandmarkets.com/research/bw98wn/companion
|